GOLDEN VALLEY, Minn.--(BUSINESS WIRE)--ProUroCare Medical Inc. (OTCBB:PUMD) announces the closing of its public offering of 3,050,000 units at $1.00 per unit (before the underwriting discount). Each unit sold consists of one share of common stock and one redeemable warrant to purchase one share of common stock at an exercise price of $1.30 per share. The Company intends to use the net proceeds of this offering to fund certain operating expenses and development costs as it pursues FDA 510(k) clearance of its ProUroScanTM prostate imaging system and to retire certain short-term liabilities.
